your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Reduction in vertebral fractures with raloxifene
Reduction in vertebral fractures with raloxifene
The cumulative proportion of women with at least one incident VFx at four years. Women with or without prevalent VFxs and who had a baseline and any follow-up radiograph were treated with placebo, or raloxifene 60 mg/day or 120 mg/day. (A) Total study population (n = 6828). (B) Women (n = 5077) who reported no use of other bone-active agents in year 4. The numbers above each bar indicate the number of women in each group who had a new VFx.